Produced by: Tarun Mishra Designed by: Manoj Kumar
Elon Musk, CEO of Neuralink, disclosed that a human patient implanted with a brain chip from the company has fully recovered and demonstrated the ability to control a computer mouse using their thoughts.
Elon Musk shared the update during a Spaces event on the social media platform X, stating that the patient showed positive neural effects and was able to manipulate a mouse cursor solely through their thoughts.
The Neuralink device comprises a chip and an electrode array with over 1,000 flexible conductors, which a surgical robot threads into the cerebral cortex of individuals. These electrodes are designed to detect thoughts related to movement.
Elon Musk envisions that an app will eventually translate these neural signals into commands to control various devices, such as phones or computers, simply by thinking. Initial users may include individuals who have lost limb function.
While Neuralink's original ambitions involved integrating the human brain with artificial intelligence, the company now appears to be prioritizing the development of brain-computer interfaces for more practical applications.
The United States Food and Drug Administration (FDA) approved Neuralink's chip for human clinical trials in May 2023. Subsequently, in September of the same year, the company initiated enrolment for a study involving people with quadriplegia.
Despite its advancements, Neuralink has faced criticism and scandals. Reports have surfaced regarding the suffering experienced by monkeys used in trials, leading to ethical concerns and debates over the treatment of experimental animals.
While Neuralink progresses with its human trials and technological advancements, questions and controversies persist, underscoring the complex ethical and scientific challenges associated with brain-computer interface technology.